Hui Kong Selected Research

Chronic Obstructive Pulmonary Disease (COPD)

1/2021	Risk factors for carbapenem-resistant Klebsiella pneumoniae infection and associated clinical outcomes.
3/2015	Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Kong Research Topics

Disease

25	Inflammation (Inflammations) 04/2024 - 11/2014
20	Hypoxia (Hypoxemia) 05/2024 - 04/2015
19	Neoplasms (Cancer) 01/2024 - 10/2003
10	Pulmonary Arterial Hypertension 01/2022 - 01/2015
10	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2014
8	Vascular Remodeling 01/2022 - 05/2013
8	Pulmonary Hypertension 01/2020 - 05/2013
6	Fibrosis (Cirrhosis) 03/2024 - 01/2018
5	Hyperplasia 12/2024 - 03/2005
5	Hypertrophy 01/2022 - 06/2012
5	Hypersensitivity (Allergy) 12/2021 - 08/2008
5	Infections 01/2021 - 01/2019
4	Necrosis 12/2024 - 06/2012
4	Adenocarcinoma of Lung 01/2024 - 09/2015
4	Stomach Ulcer (Gastric Ulcer) 01/2023 - 01/2021
4	Diabetic Retinopathy (Retinopathy, Diabetic) 12/2022 - 10/2020
4	Acute Lung Injury 01/2022 - 01/2019
4	Brain Ischemia (Cerebral Ischemia) 08/2021 - 09/2013
4	Stroke (Strokes) 08/2021 - 12/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2024 - 10/2018
3	Osteoarthritis 03/2024 - 01/2021
3	Silicosis 03/2024 - 01/2018
3	Pneumonia (Pneumonitis) 03/2024 - 06/2019
3	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2015
3	Hemorrhage 01/2023 - 01/2019
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 08/2021 - 12/2008
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 09/2015
3	Right Ventricular Hypertrophy 01/2020 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 03/2019 - 01/2018
3	Inverted Papilloma 09/2014 - 03/2005
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2024 - 01/2023
2	Liver Diseases (Liver Disease) 12/2024 - 01/2023
2	Ulcerative Colitis 12/2023 - 01/2023
2	Brain Diseases (Brain Disorder) 10/2023 - 05/2014
2	Acute Kidney Injury (Acute Renal Failure) 02/2023 - 12/2019
2	Atrophy 02/2023 - 06/2014
2	Pain (Aches) 01/2023 - 01/2020
2	Colitis 01/2023 - 10/2007
2	Hyperglycemia 12/2022 - 12/2018
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2012

Drug/Important Bio-Agent (IBA)

22	CarbonIBA 12/2024 - 11/2019
16	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2003
12	MonocrotalineIBA 01/2022 - 05/2013
9	Interleukin-6 (Interleukin 6)IBA 12/2022 - 12/2016
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
6	AntioxidantsIBA 03/2023 - 08/2015
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 08/2015
5	InterleukinsIBA 12/2024 - 09/2015
5	InflammasomesIBA 03/2024 - 09/2015
5	EnzymesIBA 01/2024 - 12/2016
5	KATP ChannelsIBA 07/2019 - 08/2015
5	CytokinesIBA 01/2019 - 12/2012
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 12/2016
4	fasudil (AT 877)IBA 01/2022 - 01/2019
4	LipopolysaccharidesIBA 01/2022 - 01/2016
3	BilirubinIBA 12/2024 - 01/2019
3	Silicon Dioxide (Silica)FDA LinkGeneric 03/2024 - 01/2018
3	NLR ProteinsIBA 03/2024 - 04/2016
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2024 - 10/2018
3	Therapeutic UsesIBA 03/2023 - 07/2019
3	Indicators and Reagents (Reagents)IBA 01/2023 - 08/2016
3	Oxygen (Dioxygen)IBA 01/2023 - 04/2015
3	Hemostatics (Antihemorrhagics)IBA 01/2023 - 01/2019
3	Adenosine Triphosphate (ATP)IBA 12/2022 - 08/2015
3	Phosphotransferases (Kinase)IBA 01/2022 - 12/2016
3	CollagenIBA 01/2022 - 08/2015
3	Hematoxylin (Haematoxylon)IBA 01/2022 - 03/2014
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 08/2015
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2022 - 03/2014
3	MicroRNAs (MicroRNA)IBA 01/2021 - 07/2016
3	Liraglutide FDA Link 10/2020 - 01/2019
3	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2020 - 01/2018
3	N- (1- methylethyl)- 1,1,2- trimethylpropylamineIBA 07/2019 - 08/2015
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2019 - 01/2018
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2019 - 01/2018
3	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 06/2012
3	tetrandrineIBA 01/2017 - 01/2014
3	Aquaporins (Water Channels)IBA 06/2014 - 08/2008
2	Superoxide DismutaseIBA 12/2024 - 01/2021
2	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2024 - 01/2023
2	Glutathione (Reduced Glutathione)IBA 12/2024 - 01/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2024 - 01/2019
2	Estradiol (Delestrogen)FDA LinkGeneric 12/2024 - 02/2023
2	Malondialdehyde (Propanedial)IBA 12/2024 - 01/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 07/2016
2	Protein Tyrosine PhosphatasesIBA 01/2024 - 08/2018
2	LipidsIBA 01/2024 - 09/2017
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 10/2023 - 01/2022
2	Histones (Histone)IBA 10/2023 - 04/2015
2	Transcription Factors (Transcription Factor)IBA 10/2023 - 04/2015
2	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
2	OsteopontinIBA 01/2023 - 01/2015
2	Dextran SulfateIBA 01/2023 - 10/2007
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023 - 08/2021
2	Retinaldehyde (Retinal)IBA 12/2022 - 01/2022
2	Evans Blue (Blue, Evans)FDA Link 01/2022 - 08/2021

Therapy/Procedure

9	Therapeutics 01/2023 - 10/2008
4	Drug Therapy (Chemotherapy) 10/2021 - 06/2016
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2024 - 12/2018